M

Michael E. Lassman

United States Military Academy(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

67

Papers

4.9K

Citations

28

h-index

46

i10-index

Michael E. Lassman is an academic researcher from United States Military Academy. The author has contributed to research in topics: Advanced Proteomics Techniques and Applications & Lipoproteins and Cardiovascular Health & Mass Spectrometry Techniques and Applications. The author has an h-index of 28, co-authored 57 publications.

Papers by this author

works
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody <u>(PART 1A</u> – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis <u>PART 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)
2024 · Bioanalysis · 11 citations

https://doi.org/10.1080/17576180.2024.2347153

2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry ( <u>Part 1A</u> – Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis <u>Part 1B</u> - Regulatory Agencies’ Inputs on Regulated Bioanalysis/BMV)
2025 · Bioanalysis · 5 citations

https://doi.org/10.1080/17576180.2025.2450194

2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in Bioanalysis; Tear Sample Collection; Radiolabeled Mass Balance Studies; Chiral Assays; Bioanalysis of Antibody-Oligonucleotide &amp; Bicycle Drug Conjugates ( <u>PART 1A</u> – Recommendations on Mass Spectrometry Assays, Chromatography, Sample Preparation and Regulated Bioanalysis Sampling, Validating, Analyzing &amp; Reporting <u>PART 1B</u> – Regulatory Agencies’ Input on Regulated Bioanalysis/BMV)
2025 · Bioanalysis · 0 citations

https://doi.org/10.1080/17576180.2026.2617084

Research topics

topics

Chat about Author

Papers

Chat

Click to start Chat